Healthcare · Profile from Healthcare Research Companion
CVS Health Corporation
The Rhode Island drugstore chain that turned itself into the most fully assembled "integrated health company" in the United States: roughly 9,000 retail pharmacies, the Caremark pharmacy benefit manager, the Aetna health insurer, Omnicare long-term-care pharmacy (until 2025), and the Oak Street Health and Signify Health care-delivery businesses. Its history is a sequence of very large bets that the pieces would be worth more together than apart, and of the write-downs, store closures and leadership changes that followed when some of them were not.
At a glance
- Founded
- 1963, Lowell, Massachusetts, as Consumer Value Stores (health and beauty aids; pharmacies added from 1967)
- Founders
- Brothers Stanley and Sidney Goldstein and partner Ralph Hoagland
- Headquarters
- Woonsocket, Rhode Island (Aetna in Hartford, Connecticut; Caremark operations in Illinois and Arizona)
- Ownership / structure
- Public company, NYSE: CVS. Owned by Melville Corporation 1969–1996; independent listed company since 1996; renamed CVS Caremark (2007) and CVS Health (2014)
- Leadership (2026)
- J. David Joyner, President and CEO (since October 2024) and Chair (listed as Chair in the FY2025 annual report); Brian Newman, CFO (from April 2025, ex-UPS); Steve Nelson, President of Aetna (from January 2025) (verify current titles)
- Segments
- Health Care Benefits (Aetna); Health Services (CVS Caremark PBM, specialty pharmacy, Health Care Delivery: Oak Street, Signify, MinuteClinic); Pharmacy & Consumer Wellness (retail and, until 2025, long-term-care pharmacy)
- Payer and patient
- Employers, health plans, Medicare (Part D and Medicare Advantage), Medicaid, ACA exchange members (to 2025) and consumers; ~26–27m Aetna medical members; ~87m PBM plan members (end-2025, 10-K; CVS reported ~94m in 2017, so the count has drifted down with client changes)
- Scale
- ~9,000 retail pharmacies (falling, after ~1,170 closures 2022–25, reported); ~300,000 employees; 2025 revenue $402.1bn (reported), among the top ten US companies by revenue
- Capital / market cap
- Self-funded through operations and debt; ~$70bn Aetna deal funded with ~$40bn of bonds; market cap peaked ~$140bn (2022) and was ~$70bn around the October 2024 CEO change and ~$55–60bn at the late-2024 share-price low, before recovering in 2025–26 (approximate, from share price × ~1.26bn shares)
- Signature moves (incl. failures)
- Founding and discount-drugstore roll-up; Caremark merger (2007); tobacco exit and rename (2014); Omnicare and Target pharmacies (2015; Omnicare bankrupt 2025); Aetna acquisition (2018); 900-store closure plan (2021); Signify and Oak Street (2023; ~$5.7bn impairment 2025); CEO change (2024); Aetna ACA exit and turnaround (2025–26)
9 strategic moves analysed
Each one gets a full strategy file in the companion: context, the decision, the financing, what happened, and the lesson.
1963
Founding Consumer Value Stores
Founding / launch
2007
Caremark Merger
Merger (stock-for-stock, contested by a rival hostile bid)
2014
Tobacco Exit
Pivot / pricing change (voluntary exit from a product category) and rebrand
2015
Omnicare and Target Pharmacies
Acquisition (two deals); Omnicare later impaired and placed in Chapter 11 (2025)
2018
Aetna Acquisition
Acquisition (vertical)
2021
Store Closures
Restructuring (footprint reduction and format change), with later acquisition of rivals' prescription files
2023
Signify and Oak Street
Acquisitions (two); later impairment and restructuring
2024
CEO Change Lynch to Joyner
Restructuring / leadership change
2025
Aetna ACA Exit and Turnaround
Divestiture / market exit and restructuring (margin turnaround)